Clinical trial
Clinical Trial of Docosahexaenoic Acid (DHA) in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment
NCT00000116 is registered in ClinicalTrials.gov with Carol Weigel DiFranco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial of Docosahexaenoic Acid (DHA) in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment
- Lead sponsor
- Carol Weigel DiFranco
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 1996
- Completion date
- September 30, 2002
- Enrollment
- 221 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.